Panacea Biotec sets Sept 29 for 42nd AGM; book closure starts Sept 25
- Panacea Biotec holds 42nd AGM on September 29, 2026, via video conferencing at 11:30 am
- Register of members closes from September 25 to September 29, 2026
- Shareholders vote on re-appointment of directors Ankesh Jain and Harshet Jain
- Rajinder Singh Manku appointed as independent director for five-year term starting July 1, 2026
- Cost auditor fee ratified at ₹1,25,000 for FY27

*this image is generated using AI for illustrative purposes only.
Panacea Biotec will hold its 42nd Annual General Meeting on September 29, 2026, at 11:30 am via video conferencing. The register of members will close from September 25 to September 29, 2026.
The meeting agenda includes the adoption of audited standalone and consolidated financial statements for FY26. Shareholders will also vote on the re-appointment of directors Ankesh Jain and Harshet Jain, who retire by rotation.
Board Appointments
A special resolution seeks approval for the appointment of Rajinder Singh Manku as an independent director. His term begins July 1, 2026, for five consecutive years. The Nomination and Remuneration Committee recommended his candidacy based on his experience in project planning and finance.
| Director | Role | Status |
|---|---|---|
| Ankesh Jain | Whole-time Director | Re-appointment |
| Harshet Jain | Whole-time Director | Re-appointment |
| Rajinder Singh Manku | Independent Director | New Appointment |
Cost Auditor Remuneration
The board proposes ratifying the remuneration for cost auditors M/s Jain Sharma & Associates. The fee is set at ₹1,25,000 for the financial year 2026-27. This amount includes out-of-pocket expenses but excludes outstation travel costs and applicable taxes.
Voting and Participation
Remote e-voting opens on September 26, 2026, at 9:00 am and closes on September 28, 2026, at 5:00 pm. The cut-off date for voting eligibility is September 22, 2026. Members can attend the meeting through the NSDL e-voting system. Physical copies of the annual report are available only upon request.
Historical Stock Returns for Panacea Biotec
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.75% | -4.32% | -9.78% | +18.10% | -7.13% | 0.0% |
How might the appointment of Rajinder Singh Manku, with his finance and project planning background, influence Panacea Biotec's future capital allocation or expansion strategies?
What specific growth targets or strategic priorities are expected to be outlined in the FY26 audited financial statements that shareholders will adopt?
Could the re-appointment of directors Ankesh Jain and Harshet Jain signal continuity in current management strategies, or are investors anticipating shifts in operational focus?


































